Peroxisomes
A newborn who cannot properly build peroxisomes will show brain malformation and liver failure. Profound developmental delay follows within months of birth. The disease is Zellweger syndrome. It exists because a single small organelle failed to assemble. That single fact reveals something important. Peroxisomes are often mentioned only in passing next to mitochondria and the The Endoplasmic Reticulum: Rough and Smooth. But they are not a minor biochemical footnote. They are an essential compartment on which entire organ systems depend. Peroxisomes are small, membrane-bound organelles found in essentially all eukaryotic cells. They are specialized for a particular kind of oxidative chemistry. They break down very-long-chain fatty acids and detoxify reactive molecules. They also synthesize lipids essential to the nervous system. All the while, they produce and safely destroy hydrogen peroxide as a byproduct. Unlike mitochondria and chloroplasts, peroxisomes carry no DNA and no ribosomes of their own. Every protein inside them is imported wholesale from the cytosol. This import uses signal sequences and receptor proteins. The mechanism is elegant, well studied, and mechanistically distinct from how proteins reach the ER or mitochondria. The concept matters because it teaches a general principle of cell biology. Compartmentalization is not just about separating reactions in space. It is about matching a chemistry to a container that can tolerate it. Hydrogen peroxide and other reactive oxygen intermediates are useful for oxidation reactions. But they are dangerous if let loose in the cytosol. The peroxisome is a purpose-built vessel that generates and disposes of this chemistry in one place. It is protected by a dense shell of catalase and other antioxidant enzymes. This article works through what peroxisomes do. It explains how proteins get inside them despite the absence of an ER-like vesicular route. It covers the genetic experiments that revealed this unusual import mechanism. It also covers the human diseases that make peroxisomal biology a matter of urgent medical importance. It closes by pointing toward a broader question. The peroxisome itself raises this question but does not answer it. Why do some organelles carry their own genome while this one does not? That question is addressed by The Endosymbiotic Theory.
- Peroxisomes are single-membrane organelles that oxidize very-long-chain fatty acids and detoxify reactive molecules, using and then destroying hydrogen peroxide (H₂O₂).
- They contain no DNA or ribosomes; every peroxisomal protein is made on free cytosolic ribosomes and imported post-translationally.
- Import depends on a C-terminal signal (PTS1) or N-terminal signal (PTS2), recognized by receptor proteins Pex5 and Pex7, and a family of PEX genes.
- Unlike almost every other import system, folded and even oligomeric proteins can be imported fully assembled, without unfolding.
- Human PEX gene mutations cause Zellweger spectrum disorders, showing peroxisome biogenesis is essential for brain and liver development.
- Peroxisomes also perform plasmalogen synthesis (myelin lipids), bile acid synthesis, and — in plants and fungi — the glyoxylate cycle.
Peroxisomes are self-contained oxidative compartments, built entirely from imported cytosolic proteins rather than internal DNA, that safely perform chemistry too dangerous to leave loose in the cytosol.
The core idea
A peroxisome is a roughly spherical organelle, typically 0.1–1 μm in diameter, bounded by a single phospholipid bilayer and packed with a dense, sometimes crystalline, protein matrix. That matrix is rich in oxidative enzymes: acyl-CoA oxidases that strip electrons from fatty acid chains, and catalase, which can make up 15–50% of total peroxisomal protein in some cell types. The defining biochemical signature of the organelle is this coupling: an oxidase transfers electrons from a substrate directly to molecular oxygen (O₂), generating hydrogen peroxide (H₂O₂) as a byproduct, and catalase then immediately breaks that hydrogen peroxide down to water and oxygen, or uses it to oxidize other toxic compounds (peroxidative reaction). This is where the organelle's name comes from — it was discovered as a site rich in "peroxide" chemistry, in electron microscopy work by Christian de Duve and colleagues in the 1960s, following up on earlier morphological descriptions by Johannes Rhodin in 1954, who called them "microbodies." Functionally, peroxisomes are the cell's dedicated site for beta-oxidation of very-long-chain fatty acids (those longer than about 22 carbons), a job mitochondria cannot do alone because mitochondrial beta-oxidation enzymes only handle shorter chains efficiently. Peroxisomes shorten these very-long-chain fatty acids through several rounds of beta-oxidation, then hand the shortened acyl-CoA fragments to mitochondria to finish oxidation and enter the citric acid cycle. Peroxisomes also degrade branched-chain fatty acids (like phytanic acid from dietary chlorophyll breakdown products), oxidize D-amino acids and polyamines, and — critically for the nervous system — carry out the first two steps of plasmalogen synthesis, a class of ether phospholipids that make up a large fraction of myelin. In plants, germinating seeds use specialized peroxisomes called glyoxysomes to run the glyoxylate cycle, converting stored fats into carbohydrates to fuel early growth before photosynthesis begins. The other defining feature of the peroxisome, and the one this article spends the most time on, is biogenesis. Peroxisomes contain no DNA and no ribosomes, unlike mitochondria and chloroplasts. Every single peroxisomal protein — matrix enzymes and membrane proteins alike — is synthesized on free ribosomes in the cytosol and imported after translation is complete, a process governed by a dedicated family of genes called PEX genes, whose products are called peroxins.
Mechanism — how peroxisomes are built and how they work
Step 1: Where do peroxisomes come from? For decades the textbook model held that peroxisomes only arise by growth and division of pre-existing peroxisomes, analogous to mitochondria — "omnis peroxisoma e peroxisomo." Work since the early 2000s, particularly from the labs of Henk Tabak and colleagues, showed this is only part of the truth. New peroxisomes can also form de novo from the endoplasmic reticulum: certain peroxisomal membrane proteins are first inserted into the ER, then bud off in ER-derived pre-peroxisomal vesicles that mature and acquire matrix proteins by import. Established peroxisomes then multiply mainly by elongation and fission, a process driven by dynamin-related GTPases (Dnm1/DRP1 family) together with the membrane-shaping peroxin Pex11, which senses fatty acid load and promotes proliferation when oxidative demand rises.
Step 2: Making matrix proteins in the cytosol. Peroxisomal matrix enzymes — catalase, acyl-CoA oxidase, and dozens of others — are translated to completion on free cytosolic ribosomes, folded, and often assembled into their final oligomeric state, before ever touching the peroxisome. This is the single most surprising fact about peroxisomal import: unlike mitochondrial or ER import, which generally require proteins to be unfolded or only partly folded to thread through a channel, peroxisomes import fully folded, cofactor-bound, even multimeric proteins.
Step 3: The targeting signals. Two peroxisomal targeting signals (PTS) direct the great majority of matrix proteins:
- PTS1: a short C-terminal tripeptide, canonically serine-lysine-leucine (SKL) or close variants, present on most peroxisomal matrix proteins (including catalase).
- PTS2: an N-terminal nonapeptide with a looser consensus, found on a smaller set of proteins including some beta-oxidation enzymes.
Step 4: Receptor recognition in the cytosol. The cytosolic receptor Pex5 recognizes PTS1-bearing proteins by binding the tripeptide in a groove formed by tetratricopeptide repeat (TPR) domains at its C-terminus. The receptor Pex7 recognizes PTS2 signals, generally with help from Pex5's longer splice isoform acting as a co-receptor in mammals. Binding occurs entirely in the cytosol, before any contact with the peroxisomal membrane.
Step 5: Docking and translocation. The cargo-loaded receptor docks at the peroxisomal membrane onto a docking complex built around Pex13 and Pex14. What happens next is mechanistically unlike any other known translocation system: rather than the receptor releasing its cargo at the membrane surface, the receptor itself is thought to insert into the membrane, transiently forming or joining a pore, and the entire folded cargo — plus receptor — moves across, or at least the cargo is translocated in a manner that does not require unfolding, permitting transport of assembled protein complexes as large as several nanometers across, far larger than a typical unfolded-polypeptide-only channel.
Step 6: Receptor recycling by ubiquitination. Once cargo is released into the matrix, Pex5 is not degraded but recycled back to the cytosol for another round. This recycling requires monoubiquitination of Pex5 at a conserved cysteine, carried out by a RING-finger ubiquitin ligase complex (Pex2, Pex10, Pex12), followed by extraction back across the membrane by the AAA-ATPase complex Pex1–Pex6, which uses ATP hydrolysis to pull the receptor out. If this extraction machinery is defective, ubiquitinated Pex5 instead accumulates and can be further polyubiquitinated and degraded — a quality-control fail-safe.
Step 7: Membrane protein insertion. Peroxisomal membrane proteins use a separate signal (mPTS) and receptor, Pex19, which binds newly made membrane proteins in the cytosol and chaperones them to the membrane docking factor Pex3, where they are inserted directly into the bilayer — again, without an internal genome or ribosome ever being involved.
Step 8: The oxidative payload. Inside the mature peroxisome, fatty acyl-CoA molecules are shortened by acyl-CoA oxidase, which passes electrons to O₂, generating H₂O₂ at each cycle. Catalase, present at very high local concentration and often forming crystalline cores visible by electron microscopy in liver and kidney peroxisomes, immediately decomposes this H₂O₂. This tight spatial coupling of peroxide generation and peroxide destruction is the functional logic of the whole organelle — it lets the cell run oxidation chemistry that would be intolerably damaging if it occurred freely in the cytosol.
The evidence
Discovery and biochemical definition (de Duve, 1965–1969). Christian de Duve's laboratory, already famous for discovering the lysosome, isolated a fraction of rat liver cells by differential and density-gradient centrifugation that was distinct from mitochondria and lysosomes. This fraction was enriched in oxidase enzymes that generate hydrogen peroxide and in catalase, which decomposes it. De Duve coined the term "peroxisome" in 1965–1966 specifically because the defining biochemical property of this organelle was hydrogen peroxide metabolism — this was not a guess but a direct biochemical assay result: fractions with peak catalase and urate oxidase activity co-sedimented at a specific density, distinct from the mitochondrial peak, showing peroxisomes are a biochemically and physically separate compartment. This work, alongside his lysosome discovery, contributed to de Duve sharing the 1974 Nobel Prize in Physiology or Medicine with Albert Claude and George Palade for work on the structural and functional organization of the cell.
The PTS1 signal (Gould, Keller, Subramani, 1987–1989). Sang Kim, Stephen Subramani, and colleagues, notably Steven Gould in Subramani's lab, asked what sequence targets a protein to peroxisomes. Using firefly luciferase — a cytosolic protein with no natural peroxisomal role — as a reporter, they found that luciferase itself was in fact imported into peroxisomes in transfected mammalian cells, and that its C-terminal tripeptide serine-lysine-leucine (SKL) was both necessary and sufficient for import. Deleting or mutating the last three residues abolished peroxisomal targeting; appending SKL to unrelated cytosolic reporter proteins (like chloramphenicol acetyltransferase) redirected them into peroxisomes. This was a clean necessary-and-sufficient demonstration, the gold standard of molecular targeting-signal proof, and it defined PTS1.
Folded-protein import (Walton, McNew, Subramani; Glover et al., 1994–1998). A separate line of evidence addressed whether peroxisomes, like mitochondria, require unfolding of cargo before import. Researchers covalently cross-linked or chemically folded reporter proteins (including gold particles coated with PTS1 peptide, and folded, disulfide-stabilized proteins) and showed these fully folded or even oligomeric cargoes were still imported into peroxisomes intact. Import of gold particles conjugated to PTS1 signal peptides, visualized by electron microscopy in the mid-1990s by Walton, Hettema, and colleagues, directly showed particles far larger than any known unfolded-polypeptide channel crossing the peroxisomal membrane, providing structural evidence that peroxisomal translocation tolerates folded, even multimeric, substrates — a sharp mechanistic contrast with the mitochondrial and ER import systems the student already knows.
Human genetics — PEX genes and Zellweger syndrome (Goldfischer et al. 1973; complementation studies, 1990s). The final and most clinically important line of evidence came from patients. Sidney Goldfischer and colleagues in 1973 showed that liver cells from infants with Zellweger syndrome, a fatal developmental disorder, completely lacked morphologically identifiable peroxisomes, even though other organelles appeared normal. This was the first evidence that a whole-organelle biogenesis defect, not just a single enzyme deficiency, could cause severe human disease. Subsequent cell-fusion complementation studies in the 1980s–1990s, using fibroblasts from many Zellweger-spectrum patients, sorted patients into distinct complementation groups — cells from patients in different groups could complement each other's peroxisome-assembly defect when fused, while cells from the same group could not. This genetically proved that multiple distinct genes (now known as PEX1 through at least PEX26 in humans) are each independently required for peroxisome biogenesis, and it was this human genetic dissection, combined with parallel yeast genetic screens for peroxisome-assembly mutants (pex mutants in Saccharomyces cerevisiae and Pichia pastoris, pioneered by groups including those of Wolf-H. Kunau and James Cregg), that identified the peroxin proteins and built the mechanistic pathway described above.
Worked examples
Example 1 — Reasoning through a Zellweger-spectrum diagnosis. A newborn presents with severe hypotonia (low muscle tone), distinctive facial features, liver dysfunction, and seizures. Blood tests show markedly elevated very-long-chain fatty acids (VLCFA), elevated phytanic acid, and reduced plasmalogen levels in red blood cells. Reasoning: VLCFA and phytanic acid degradation and plasmalogen synthesis are all specifically peroxisomal functions; a defect that affects all three simultaneously, rather than just one, points away from a single-enzyme defect and toward a failure of the organelle itself. If only VLCFA were elevated with normal plasmalogens, a diagnosis of X-linked adrenoleukodystrophy (ALD) would be favored — that disease affects only the peroxisomal membrane transporter ABCD1 (encoded by the ALD gene) that imports VLCFA-CoA into an otherwise structurally normal peroxisome, leaving other peroxisomal functions intact. Because this infant shows the combined defect, the clinical picture is consistent with a PEX gene mutation causing failure of peroxisome assembly itself — confirmed by fibroblast studies showing empty "ghost" peroxisomal membranes (detectable by immunostaining for PMP70, a membrane protein, in the absence of matrix enzyme staining) — the classic biochemical signature of Zellweger syndrome. Complementation testing (fusing the patient's cells with cells from patients of known PEX complementation groups) would then identify exactly which PEX gene is affected, since group assignment predicted the underlying genetic defect even before individual genes were cloned.
Example 2 — Quantitative reasoning about catalase and H₂O₂ flux. Suppose a hepatocyte peroxisome contains catalase at an intraperoxisomal concentration on the order of 1 mM (a physiologically realistic estimate given catalase's high abundance in liver peroxisomes), and catalase's turnover number (kcat) for H₂O₂ decomposition is roughly 10⁷ per second per active site — one of the fastest enzyme turnover numbers known in biology. Even if fatty acid oxidase activity in the same organelle generates H₂O₂ continuously, back-of-envelope reasoning shows catalase's maximum possible decomposition rate vastly exceeds any realistic oxidase-driven production rate, meaning steady-state H₂O₂ concentration inside a healthy peroxisome remains extremely low despite constant flux through it. This explains, mechanistically, why peroxisomes are not simply "little bags of poison" — the coupling of production and destruction is so tightly matched, and catalase so fast, that free H₂O₂ rarely escapes into the cytosol under normal conditions. It also explains a clinical corollary: if catalase itself is deficient (as in the rare human condition acatalasemia) H₂O₂ can accumulate and leak, causing oxidative tissue damage, most classically manifesting as oral gangrene (Takahara's disease) in affected patients — a real, if rare, illustration of what happens when the "destruction" half of the peroxisomal reaction pair fails.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "Peroxisomes are just small, defective mitochondria." | They perform distinct chemistry (direct oxidase-to-O₂ electron transfer, not an electron transport chain) and have no shared evolutionary or genomic relationship implied by size alone. |
| "All organelles without their own DNA are 'derived' from the ER and don't really matter as independent compartments." | Peroxisomes are functionally indispensable and biochemically distinct; ER-derived biogenesis explains partial origin of new peroxisomal membranes, not a lack of functional identity. |
| "Hydrogen peroxide is simply a toxic waste product peroxisomes get rid of." | H₂O₂ generation is often the functional point of the oxidase reaction (useful electron sink), and catalase also uses H₂O₂ productively in peroxidative detoxification reactions, not merely destructive ones. |
| "Peroxisomal protein import must involve unfolding, like mitochondrial import." | Folded and even oligomeric proteins are imported intact — a defining, unusual feature proven directly with gold-particle and cross-linked cargo experiments. |
| "A missing peroxisomal enzyme and a missing whole peroxisome cause the same kind of disease." | Single-enzyme defects (e.g., X-ALD, affecting only VLCFA transport) are typically milder and more selective than PEX-gene biogenesis defects (Zellweger spectrum), which knock out many functions at once. |
The scientist behind it
Christian de Duve trained as a physician in Belgium and turned to biochemistry through his work on insulin and cellular fractionation in the 1940s–50s at the Catholic University of Louvain. Using increasingly refined differential centrifugation of rat liver homogenates, he and his coworkers discovered the lysosome in 1955, showing acid hydrolase enzymes were compartmentalized in a distinct sedimentable fraction rather than free in the cytosol as previously assumed. A decade later, applying the same rigorous fractionation-and-enzyme-assay logic, his group identified a second, separate small organelle defined by co-sedimenting catalase and H₂O₂-generating oxidases — the peroxisome. De Duve was characteristically insistent that organelles be defined operationally, by what enzymes physically co-purify together, rather than by appearance alone under the microscope; this biochemical rigor is why the peroxisome's discovery is considered a model of how careful subcellular fractionation reveals compartments invisible to earlier, purely morphological anatomy of the cell.
Origins · 1 minChristian de Duve and how this was discovered
Where this matters today
Peroxisomal biology sits at the center of real diagnostic and therapeutic medicine. Newborn and prenatal screening panels test blood or amniotic fluid for elevated very-long-chain fatty acids and reduced plasmalogens specifically to catch Zellweger-spectrum disorders and X-linked adrenoleukodystrophy (X-ALD) before symptoms progress; X-ALD gained public attention through the 1992 film Lorenzo's Oil, which dramatized a family's real search for a dietary treatment (a mixture of oleic and erucic acid, now called "Lorenzo's Oil") aimed at lowering VLCFA accumulation, though its clinical efficacy remains modest and controversial compared to newer approaches. Since 2016, the FDA has approved lentiviral gene therapy (elivaldogene autotemcel, brand name Skysona) that reintroduces a functional ABCD1 gene into a patient's own hematopoietic stem cells to treat cerebral X-ALD, directly built on decades of understanding peroxisomal fatty acid transport. Peroxisome proliferation is also a target in metabolic pharmacology: the PPAR-alpha (peroxisome proliferator-activated receptor alpha) nuclear receptor, discovered through studies of drugs that dramatically increase peroxisome number in rodent liver, is the molecular target of fibrate drugs (such as fenofibrate) used clinically to lower triglycerides, an application discovered because researchers were trying to understand why certain compounds caused peroxisome proliferation in the first place. In agriculture and plant biology, understanding glyoxysomal peroxisomes and the glyoxylate cycle informs engineering of oilseed crops for altered lipid mobilization during germination. And in basic cell biology, the peroxisome's ability to import fully folded, cofactor-loaded, oligomeric proteins remains a valuable and still not completely mechanistically resolved model system for understanding how biological membranes can be made selectively and transiently permeable to very large cargo — a question with implications well beyond this one organelle, and one that echoes forward into questions about how organelles with genuinely different evolutionary origins, addressed by The Endosymbiotic Theory, manage their own distinct import logistics.
Ask the tutor: How does the peroxisome's lack of its own genome compare mechanistically to mitochondrial biogenesis, and what does that contrast teach us about the endosymbiotic origin of organelles?
Do peroxisomes have their own DNA like mitochondria?
No. Peroxisomes contain no DNA and no ribosomes of their own, unlike mitochondria and chloroplasts, which retain small genomes reflecting their bacterial evolutionary origins. Every peroxisomal protein — matrix enzymes such as catalase and acyl-CoA oxidase, and membrane proteins such as the peroxins — is encoded in the nuclear genome, synthesized on free cytosolic ribosomes, and imported after translation. This absence of an internal genome is one reason peroxisomes are thought to have originated differently from mitochondria, likely arising and being maintained through membrane budding from the ER combined with fission of pre-existing peroxisomes, rather than through the engulfment of a free-living bacterium proposed by endosymbiotic theory for mitochondria and chloroplasts.
Why does hydrogen peroxide need its own dedicated organelle?
Hydrogen peroxide is a reactive molecule that can damage proteins, lipids, and DNA if it accumulates freely in the cytosol, particularly through Fenton chemistry with free iron that generates highly damaging hydroxyl radicals. Peroxisomes concentrate both the enzymes that generate H₂O₂ (fatty acid oxidases) and the enzyme that destroys it (catalase) within one small, enclosed compartment. This spatial coupling means H₂O₂ is typically decomposed at essentially the same location and rate it is produced, keeping cytosolic H₂O₂ levels low under normal conditions. It is a clean example of compartmentalization solving a chemical safety problem rather than merely an organizational one.
What actually goes wrong in Zellweger syndrome?
Zellweger syndrome results from mutations in PEX genes (most commonly PEX1) that encode proteins required to assemble functional peroxisomes. Patients' cells contain "peroxisomal ghosts" — membrane structures that lack the imported matrix enzymes, because the import machinery itself is broken. This causes accumulation of very-long-chain fatty acids and phytanic acid, and a deficiency of plasmalogens needed for normal myelin. The result is severe brain malformation, profound hypotonia, liver dysfunction, and characteristic facial features, with most classic cases fatal within the first year of life. Milder PEX mutations cause a spectrum of less severe disease, reflecting partial rather than complete loss of peroxisome function.
Is X-linked adrenoleukodystrophy the same disease as Zellweger syndrome?
No, though both are peroxisomal disorders and both cause elevated very-long-chain fatty acids. X-ALD is caused by mutation in a single gene, ABCD1, which encodes a peroxisomal membrane transporter needed to import VLCFA-CoA into an otherwise structurally and functionally normal peroxisome. Zellweger syndrome instead results from failure of overall peroxisome assembly (PEX gene mutations), knocking out many peroxisomal functions simultaneously, not just fatty acid transport. X-ALD is typically milder at onset and more variable in severity, sometimes presenting in childhood with progressive neurologic decline (cerebral ALD) or in adulthood with a slower spinal cord disease (adrenomyeloneuropathy), whereas classic Zellweger syndrome is usually severe and detectable in infancy.
How do proteins actually get inside a peroxisome if there's no vesicle trafficking involved?
Peroxisomal matrix proteins are synthesized and folded completely in the cytosol, then recognized by a soluble receptor protein — Pex5 for the common C-terminal PTS1 signal, or Pex7 for the less common N-terminal PTS2 signal. This receptor-cargo complex diffuses to the peroxisomal membrane and docks onto a complex built around Pex13 and Pex14. Unlike mitochondrial or ER import, which typically require unfolded polypeptide chains threading through narrow channels, peroxisomal import can translocate fully folded and even oligomeric proteins across the membrane by a mechanism still not completely resolved at the structural level, though it is known to require the receptor itself, ATP-dependent receptor recycling, and does not depend on classical vesicular trafficking machinery like COPI or COPII coats.
Do plant cells have peroxisomes too, and do they do the same thing?
Yes, and plant peroxisomes are functionally diverse in ways animal peroxisomes are not. In addition to fatty acid oxidation, germinating oilseeds contain specialized peroxisomes called glyoxysomes that run the glyoxylate cycle, converting stored triglycerides into sugars to fuel the seedling before photosynthesis begins — a metabolic pathway animal cells lack entirely. In photosynthetic leaf tissue, a different set of "leaf peroxisomes" participates in photorespiration, processing a toxic byproduct (glycolate) generated when the photosynthetic enzyme RuBisCO fixes oxygen instead of carbon dioxide. This shows the same basic organelle chassis — single membrane, imported matrix proteins, oxidase/catalase coupling — has been repurposed for very different metabolic tasks across kingdoms.
Why don't we call peroxisomes "organelles derived from mitochondria" if they share some oxidative chemistry?
Because sharing a general category of chemistry (oxidation reactions involving oxygen) does not imply shared ancestry or shared biogenesis. Mitochondria run an electron transport chain across a double membrane, using a proton gradient to synthesize ATP via chemiosmosis, and carry their own small circular genome reflecting descent from an ancient bacterial endosymbiont. Peroxisomes have a single membrane, no internal genome, no electron transport chain, and instead directly transfer electrons from substrate to molecular oxygen via oxidase enzymes, generating H₂O₂ rather than a proton gradient. The two organelles solve different chemical problems using entirely different membrane architectures, protein import systems, and evolutionary histories.